MAURA CASEY: Open Payments
NPI 1093111486 · WEST BABYLON, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$814 in 41 payments from 15 companies in 2025. Trend: 2023 $354 · 2024 $589 · 2025 $814
Food & beverage: $814
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $178 |
| Xeris Pharmaceuticals, Inc. | 4 | $83 |
| Abbott Laboratories | 4 | $82 |
| Novo Nordisk Inc | 3 | $64 |
| Amgen Inc. | 3 | $58 |
| ABBVIE INC. | 2 | $52 |
| Otsuka America Pharmaceutical, Inc. | 2 | $48 |
| Lilly USA, LLC | 2 | $41 |
| SANOFI-AVENTIS U.S. LLC | 2 | $40 |
| Novartis Pharmaceuticals Corporation | 2 | $38 |
Products named: AIRSUPRA, RECORLEV, FREESTYLE LIBRE 3, OTEZLA, VRAYLAR, REXULTI, Ozempic, TZIELD.
Industry payments across NY — which companies pay providers there.
